Dr. Blagosklonny’s Strategy: From Osimertinib to Preemptive Combinations

Oncotarget

June 6, 2024
This article dissects Dr. Mikhail V. Blagosklonny’s paradigm-shifting perspective on preemptive combinations for treating EGFR-mutant non-small cell lung cancer. continue reading »

Synergistic Cytotoxicity of HDAC and PARP Inhibitors and Decitabine in Pancreatic Cancer Cells: Implications for Novel Therapy

News

June 5, 2024
PRESS RELEASE: On June 3, 2024, a new research paper was published in Oncotarget, entitled, “Synergistic cytotoxicity of histone deacetylase and poly-ADP ribose polymerase inhibitors and decitabine in pancreatic cancer cells: Implications for novel therapy.” continue reading »

Serine Racemase Expression in the Brain During Aging in Male and Female Rats

News

June 5, 2024
PRESS RELEASE: A new research paper was published in Aging's Volume 16, Issue 10, entitled, “Serine racemase expression profile in the prefrontal cortex and hippocampal subregions during aging in male and female rats.” continue reading »

The Price of Hope: CAR-T Therapy in Pediatric Leukemia

News

May 17, 2024
PRESS RELEASE: On April 25, 2024, a new editorial was published in Oncoscience, entitled, “The price of hope: CAR-T therapy in pediatric leukemia.” continue reading »

When Does Human Life Truly Begin?

Aging

May 16, 2024
In this fascinating new review, researchers Polina A. Loseva and Vadim N. Gladyshev from Harvard Medical School discuss the beginning of becoming a human. continue reading »